Cagrilintide is an amylin analogue that helps regulate appetite. In a randomized trial of over 3400 patients who were overweight or obese and had 1 weight related complication, individuals assigned to a combination EASD 2023: meta analysis shows tirzepatide superiority to semaglutide Clinical Trials Arena Cagrilintide and semaglutide together drive record weight loss in global trial Retatrutide vs Mounjaro (Tirzepatide): Which is Better? Tirzepatide vs. Semaglutide: Which Weight Loss Medication is Right for You? BodyByBariatrics